{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:42:21Z","timestamp":1790854941001,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"United States Public Health Service","award":["NS059921"],"award-info":[{"award-number":["NS059921"]}]},{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.expneurol.2011.08.010","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T21:31:10Z","timestamp":1313530270000},"page":"119-125","source":"Crossref","is-referenced-by-count":36,"title":["Reduced striatal acetylcholine efflux in the R6\/2 mouse model of Huntington's disease: An examination of the role of altered inhibitory and excitatory mechanisms"],"prefix":"10.1016","volume":"232","author":[{"given":"Andrew M.","family":"Farrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Abercrombie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.08.010_bb0005","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1523\/JNEUROSCI.17-21-08498.1997","article-title":"Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism","volume":"17","author":"Abercrombie","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3565(24)36622-4","article-title":"Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo","volume":"281","author":"Acquas","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnana.2011.00006","article-title":"Centrality of striatal cholinergic transmission in Basal Ganglia function","volume":"5","author":"Bonsi","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.brainresbull.2006.02.011","article-title":"Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease","volume":"69","author":"Brooks","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0025","article-title":"Selective cognitive impairment in the YAC128 Huntington's disease mouse","author":"Brooks","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0030","doi-asserted-by":"crossref","first-page":"14390","DOI":"10.1523\/JNEUROSCI.2167-10.2010","article-title":"The parafascicular thalamic nucleus concomitantly influences behavioral flexibility and dorsomedial striatal acetylcholine output in rats","volume":"30","author":"Brown","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0028-3908(98)00199-3","article-title":"Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP","volume":"38","author":"Calabresi","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","article-title":"In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington's disease","volume":"5","author":"Callahan","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0055","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nlm.2009.06.002","article-title":"Progressive imbalance in the interaction between spatial and procedural memory systems in the R6\/2 mouse model of Huntington's disease","volume":"92","author":"Ciamei","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0065","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1523\/JNEUROSCI.22-04-01407.2002","article-title":"Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol","volume":"22","author":"Cobb","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-3565(25)39069-5","article-title":"D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum","volume":"242","author":"Consolo","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-2999(90)90456-G","article-title":"Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat","volume":"186","author":"Damsma","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0022-3565(25)12934-0","article-title":"Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes","volume":"277","author":"DeBoer","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-2999(96)00761-3","article-title":"Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors","volume":"317","author":"DeBoer","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.coph.2006.08.010","article-title":"Plastic abnormalities in experimental Huntington's disease","volume":"7","author":"Di Filippo","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2010.06.017","article-title":"Thalamic gating of corticostriatal signaling by cholinergic interneurons","volume":"67","author":"Ding","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0014-2999(86)90447-4","article-title":"Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum","volume":"129","author":"Fage","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainresbull.2003.12.004","article-title":"Regional and progressive change in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation","volume":"63","author":"Freeman","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1046\/j.1471-4159.2003.01916.x","article-title":"Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6\/2 transgenic mice","volume":"86","author":"Gourfinkel-An","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004010050408","article-title":"Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease","volume":"91","author":"Heinsen","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-3565(25)38363-1","article-title":"Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors","volume":"266","author":"Imperato","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington's disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0155","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1152\/jn.00171.2007","article-title":"Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys","volume":"98","author":"Kliem","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0306-4522(92)90293-B","article-title":"Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat","volume":"51","author":"Lapper","year":"1992","journal-title":"Neuroscience"},{"issue":"Pt 5","key":"10.1016\/j.expneurol.2011.08.010_bb0165","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington's disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2011.08.010_bb0170","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","article-title":"Evidence for specific cognitive deficits in preclinical Huntington's disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0175","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0028-3932(99)00035-4","article-title":"Discrimination, reversal, and shift learning in Huntington's disease: mechanisms of impaired response selection","volume":"37","author":"Lawrence","year":"1999","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0180","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0306-4522(83)90102-1","article-title":"The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?","volume":"10","author":"Lehmann","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0185","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0190","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0195","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0200","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2217\/fnl.10.41","article-title":"Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium","volume":"5","author":"Miller","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1471-4159.2001.00059.x","article-title":"Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease","volume":"76","author":"Morton","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","article-title":"A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease","volume":"21","author":"Morton","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2011.01.036","article-title":"Impaired dopamine release and uptake in R6\/1 Huntington's disease model mice","volume":"492","author":"Ortiz","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington's disease mice","volume":"11","author":"Peters\u00e9n","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2005.10.009","article-title":"Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons","volume":"22","author":"Picconi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nlm.2008.09.008","article-title":"Acetylcholine activity in selective striatal regions supports behavioral flexibility","volume":"91","author":"Ragozzino","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0240","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0245","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/cne.10247","article-title":"Nigral and pallidal inputs to functionally segregated thalamostriatal neurons in the centromedian\/parafascicular intralaminar nuclear complex in monkey","volume":"447","author":"Sidib\u00e9","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0250","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington's disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0255","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0306-4522(92)90027-Y","article-title":"Regulation of the activity of striatal cholinergic neurons by dopamine","volume":"47","author":"Stoof","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0260","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1523\/JNEUROSCI.2411-08.2008","article-title":"Recurrent inhibitory network among striatal cholinergic interneurons","volume":"28","author":"Sullivan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(95)11888-4","article-title":"Extracellular gamma-aminobutyric acid in the substantia nigra reticulata measured by microdialysis in awake rats: effects of various stimulants","volume":"197","author":"Timmerman","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s002130100908","article-title":"Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies","volume":"159","author":"Trevitt","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0280","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0285","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1471-4159.2003.01704.x","article-title":"Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum","volume":"85","author":"Vetter","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.08.010_bb0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.neuron.2006.04.010","article-title":"Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons","volume":"50","author":"Wang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2011.08.010_bb0295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroscience.2004.11.006","article-title":"Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum","volume":"131","author":"Zackheim","year":"2005","journal-title":"Neuroscience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:47:04Z","timestamp":1741466824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0014488611002731"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.08.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}